Ares Capital’s $2.6 Billion MidCap Financial Deal Sends MFIC Shares Higher
Ares Capital’s $2.6 billion acquisition of MidCap Financial, paid in cash and stock, puts private-credit consolidation under the market spotlight.
Incyte’s $152 Price Target Holds as H.C. Wainwright Reviews Cancer-Drug Data
H.C. Wainwright kept Incyte’s $152 price target after reviewing new cancer-drug data, signaling cont…
Summit Therapeutics’ $30 Target Holds as Ivonescimab Data Deliver Another Phase 3 Win
Back-to-back bullish analyst calls follow additional ivonescimab data, keeping Summit Therapeutics a…
Pfizer’s Talzenna-Xtandi Approval Expansion Adds New Oncology Catalyst for PFE
The FDA’s expanded approval of Pfizer’s Talzenna-Xtandi combination gives PFE a fresh regulatory cat…
Meta’s Reported $95 Billion AI Funding Push Raises the Capital-Spending Stakes
Meta’s reported plan to raise $95 billion for AI infrastructure puts capital spending, leverage and …
Surgery Partners’ $5.7 Billion Takeover Puts Outpatient-Care Consolidation in Focus
Bon Secours’ reported $5.7 billion acquisition of Surgery Partners offers investors a reference poin…
Faraday Future Spins Out Nasdaq-Listed Humanoid-Robotics Platform
Faraday Future has completed the transfer of its robotics business to Nasdaq-listed FF EAI Robotics …
SciSparc Stock Jumps 38.56% as Traders Track SCI-110 and AI Pivot
SciSparc shares rose 38.56% as traders focused on the SCI-110 trial and an AI pivot, though confirme…
Aurora Cannabis Investors Weigh Alberta Securities Commission Decision
The Alberta Securities Commission dismissed a Curaleaf application, giving Aurora investors a regula…
Acuity’s $675 Million Parameter Technologies Deal Expands Distech Controls
Acuity’s $675 million acquisition of Parameter Technologies would expand Distech Controls and put cl…